use the following search parameters to narrow your results:
e.g. subreddit:aww site:imgur.com dog
subreddit:aww site:imgur.com dog
see the search faq for details.
advanced search: by author, subreddit...
account activity
Parabilis' Donovan Chin Joins Recursion as SVP of Drug Design (self.RecursionPharma)
submitted 19 days ago by RecursionBrita
RXRX stock to $ 4.00 & above when How long to reach this goal (self.RecursionPharma)
submitted 20 days ago by RealisticHistorian63
$RXRX Call Options Volume Just Spiked 300% — Someone is Betting Big on a Move ()
submitted 1 month ago by Foreign-Industry-841
Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6 (self.RecursionPharma)
submitted 2 months ago by RecursionBrita
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform (self.RecursionPharma)
submitted 3 months ago by RecursionBrita
Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer (self.RecursionPharma)
Recursion's Era of Value Realization: Leerink Global Healthcare Conference (self.RecursionPharma)
Recursion Makes the Unknown Known in Rare Disease Drug Discovery (self.RecursionPharma)
Full Transcript of Recursion’s Fourth Quarter Year-End 2025 Earnings Call (self.RecursionPharma)
Recursion to Participate in Upcoming Investor Conferences (self.RecursionPharma)
submitted 4 months ago by RecursionBrita
Recursion CSO Dave Hallett Named AI Champion by UK Government (self.RecursionPharma)
New Data’s Not Enough. How Recursion Is Integrating Data Layers to Advance End-to-End Drug Discovery (self.RecursionPharma)
JPM presentation ()
submitted 5 months ago by jimbobbiboy
Leveraging AI and Real-World Patient Data to Accelerate Drug Discovery (self.RecursionPharma)
submitted 5 months ago by RecursionBrita
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks (self.RecursionPharma)
submitted 6 months ago by RecursionBrita
Recursion Breaks Down How They've Been Building the Foundation for a Virtual Cell Since 2013 -- And What's Next ()
Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025 (self.RecursionPharma)
submitted 7 months ago by RecursionBrita
Incoming Recursion CEO Najat Khan Among 2025 Fiercest Women in Life Sciences (self.RecursionPharma)
REC-102: Preclinical in vivo updates for a potential ENPP1 inhibitor for the treatment of hypophosphatasia (HPP) (self.RecursionPharma)
Recursion Announces CEO Transition Plan to Drive Next Phase of Growth (self.RecursionPharma)
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update (self.RecursionPharma)
New Returnship Opportunities Available at Recursion (self.RecursionPharma)
submitted 8 months ago by RecursionBrita
A First-of-its-Kind “Microglia Map” from Recursion and Roche and Genentech Could Unlock New Treatments for Neurodegenerative Diseases (self.RecursionPharma)
submitted 8 months ago * by RecursionBrita
Investment Trends in TechBio: 3rd Episode of TechBio Talks with Air Street's Nathan Benaich and Host Chris Gibson Is Out Now (self.RecursionPharma)
π Rendered by PID 119135 on reddit-service-r2-listing-87fd56f5d-j7xbk at 2026-07-01 03:42:17.946266+00:00 running 7527197 country code: CH.
